Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03839537
Other study ID # K180303J
Secondary ID 2018-A00811-54
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2019
Est. completion date June 11, 2020

Study information

Verified date July 2021
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Brief Summary Short description of the protocol intended for the lay public. Include a brief statement of the study hypothesis. (Limit: 5000 characters) Example: The purpose of this study is to determine whether prednisone, methotrexate, and cyclophosphamide are effective in the treatment of rapidly progressive hearing loss in both ears due to autoimmune inner ear disease (AIED). This project is part of a research field on the role, not yet fully understood, of atmospheric pollution, especially from road traffic, on respiratory health and allergies, particularly on the development / onset of symptoms and functional disturbances. The ultrafine fraction of particles (UFPs - particles smaller than 100 nm in diameter) is of recent interest because of their ability to induce inflammatory effects, oxidative stress and may contribute to the exacerbation of asthma symptoms in susceptible individuals. UFPs, with their high number concentration and surface area and their small diameter are able not only to convey other contaminants, but also to contribute to a high deposition efficiency, into the alveoli in the lungs. Recently it appeared relevant to be interested in black carbon (BC), components of PM2.5 (particulate matter with a diameter less than 2.5 micrometers), suspected of being responsible for their toxicity. Current epidemiological knowledge of the effects of UFPs and BC are few as compared to those on fine particles. Some professionals, such as police, drivers (taxis, truckers ...), delivery men, postal workers, workers on roads and highways, etc. are heavily exposed, during their working hours, to air pollution due to road traffic. These occupational groups appear to be at greater risk for developing respiratory, cardiovascular and neurological diseases than the general population. Occupational exposure to diesel exhaust has been associated with an increased risk of lung cancer mortality and chronic obstructive pulmonary disease. Occupational exposure to UFPs and BC has rarely been measured due to a lack of suitable devices. Therefore, this project's originality consists in measuring UFPs and BC by using portable devices developed in the recent years. The use of these devices, linking their recordings with ventilatory measures and repeating them, offers the rare opportunity to study the short-term respiratory health impact of this occupational exposure, which has never been described in the literature. Our research aims to: 1/ quantify the occupational exposure of taxi drivers to UFP, BC, oxides of carbon (CO, CO2) and to nitrogen dioxide (NO2), 2/ identify spatio-temporal variability and patterns of exposure related to occupational tasks, 3/ study the impact of this occupational exposure to UFP and BC on ventilation performances and respiratory symptoms.


Description:

The study is based on a random sampling of 100 taxi drivers, working full-time day shift, in Paris, members of three Trade Unions. It will be conducted over a period of two years in warm and cold season. The research will begin with an inclusion clinical examination. It consists on determining the overall health status of the participants by administering a standardized questionnaire and performing spirometry test, prick test and FENO measurement. The exposure assessment will be based on continuous measurement of UFP, BC, carbon monoxide (CO) and NO2, by portable devices during a working day (± 11 hours). On the same day, two spirometry tests and two measurements of exhaled carbon monoxide will be performed at the beginning and at the end of the shift, using handheld devices. Multivariate analysis will provide spatio-temporal distributions of individual exposures and their determinants. Generalized Estimating Equations (GEE) multivariate models will be used to determine the relation between exposure (UFP, BC) and respiratory symptoms, ventilation performances, adjusting for potential confounding/modifying factors.


Recruitment information / eligibility

Status Completed
Enrollment 56
Est. completion date June 11, 2020
Est. primary completion date June 11, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age > 18 years - Full time licensed taxi driver - Subjects with more than 6 months of job tenure (as a taxi driver) - Subjects affiliated to a social security scheme - Subjects must have signed an informed consent and are willing to participate in the study Exclusion Criteria: - Subjects having difficulty to understand the French language - Subjects with less than 6 months of job tenure (as a taxi driver)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exposure measurement
2 measurements per subject (in warm season and in cold season) Devices placed inside taxi vehicles on the passenger seat in a sampling bag
Spirometry test
2 measurements per subject - before and after the work shift - in warm and cold seasons Subject will inhale and exhale in the device
Diagnostic Test:
Exhaled carbon monoxide test
2 measurements per subject - before and after the work shift - in warm and cold seasons Subject will exhale in the device
Skin allergy test
- Performed by a physician during the inclusion clinical examination
Spirometry test
- Performed by a physician during the inclusion clinical examination
Fractional Exhaled Nitric Oxide Testing
- Performed by a physician during the inclusion clinical examination

Locations

Country Name City State
France Paris Descartes University Paris

Sponsors (4)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris Centre national de la recherche scientifique - Lebanon (CNRS-L), French Environment and Energy Management Agency, University of Paris 5 - Rene Descartes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean number of ultrafine fraction of particles (UFP) per cm3 of air [from 1000 to 1000000 particles (pt)/cm3] - 8-11 h recording on 1 working day for each subject - repeated measurement in cold and warm seasons (6 months apart) 6 months
Primary Mean concentration of black carbon (BC) measurement of BC exposure concentrations per cubic meter (ng/m3) by the microAeth AE51 - 8-11 h recording on 1 working day for each subject - repeated measurement in cold and warm seasons (6 months apart) 6 months
Primary Difference between the values of the forced vital capacity (FVC) measured before and after work shift measurement of FVC in liters by a portable spirometer before and after the work shift according to procedures described by The European Respiratory Society and the American Thoracic Society (2005) - 2 measurements per subject - before and after the work shift - 1 working day Repeated measurement in cold and warm seasons (6 months apart) Overall period: 2 working days (one in each season) - 36 months 36 months
Primary Difference between the values of the forced expiratory volume in one second (FEV1) measured before and after work shift measurement of FEV1 in liters by a portable spirometer before and after the work shift according to procedures described by The European Respiratory Society and the American Thoracic Society (2005) -2 measurements per subject - before and after the work shift - 1 working day Repeated measurement in cold and warm seasons (6 months apart) Overall period: 2 working days (one in each season) - 36 months 36 months
Primary Difference between the values of the forced expiratory flow between 25 and 75 % of FVC (FEF25-75) measured before and after work shift measurement of FEF25-75 in liters by a portable spirometer before and after the work shift according to procedures described by The European Respiratory Society and the American Thoracic Society (2005). -2 measurements per subject - before and after the work shift - 1 working day Repeated measurement in cold and warm seasons (6 months apart) Overall period: 2 working days (one in each season) - 36 months 36 months
Primary Difference between the rates of the peak expiratory flow (PEF) measured before and after work shift measurement of PEF in liter per second (L.s-1) by a portable spirometer before and after the work shift according to procedures described by The European Respiratory Society and the American Thoracic Society (2005)-2 measurements per subject - before and after the work shift - 1 working day Repeated measurement in cold and warm seasons (6 months apart) Overall period: 2 working days (one in each season) - 36 months 36 months
Primary Acute respiratory symptoms through self-administered questionnaire by means of a self-completion questionnaire, participants report their acute respiratory symptoms felt during the measurement day - Reported before and after the work shift per subject - In cold and warm seasons (6 months apart)- Overall period: reported during 2 working days (one in each season) - 36 months 36 months
Secondary Characteristics of vehicles recorded by a self-administered questionnaire fuel, age and type of the vehicle, air conditioning, air cabin filter reported by a self-administered questionnaire - after the work shift per subject - In cold and warm seasons (6 months apart) Overall period: reported during 2 working days (one in each season) - 36 months 36 months
Secondary Characteristics of the trips recorded by a self-administered questionnaire speed, opened/closed windows, smoking, breaks, etc. reported by a self-administered questionnaire - after the work shift per subject - In cold and warm seasons (6 months apart) Overall period: reported during 2 working days (one in each season) - 36 months 36 months
See also
  Status Clinical Trial Phase
Completed NCT03279458 - Non-invasive Tidal Volume Monitoring Using the Linshom Respiratory Monitoring Device N/A
Not yet recruiting NCT05532748 - Distribution of Pulmonary Ventilation With the Modified Pachon Incentive vs. Branded Respiratory Incentive N/A
Completed NCT02864017 - Immuno Nutrition by L-citrulline for Critically Ill Patients N/A
Withdrawn NCT03822689 - Comparison of Ventilation Tubes Among Anesthetized Pediatrics N/A
Completed NCT03057535 - Impact of NaHCO3- on Exercise Hyperpnea Early Phase 1
Recruiting NCT03577860 - Ventilation and Pulmonary Aeration, Electrical Impedance Tomography, Interscalene Brachial Plexus Block N/A
Recruiting NCT04237727 - CAvent-Ventilation During Advanced Cardiopulmonary Resuscitation in Out-of-hospital Cardiac Arrest- a Descriptive Study
Completed NCT03873233 - Flow Controlled Ventilation (FCV) With the Evone Ventilator and Tritube Versus Volume Controlled Ventilation (VCV) Phase 3
Completed NCT04667936 - Evaluation of Sedation in COVID-19 ARDS
Recruiting NCT05105932 - The Study of Regional Lung Ventilation-perfusion by EIT
Terminated NCT04274686 - Tegarderm® Placement for Bag Mask Ventilation in the Bearded Patient N/A
Completed NCT02828943 - Ventilatory Muscle Training in Stroke Phase 3
Completed NCT02825433 - Observing Changes in Ventilation Pattern During Procedural Sedation N/A